Eight‐year outcomes of aortic valve replacement with the Carpentier‐Edwards PERIMOUNT Magna Ease valve
Steven Tsui(Papworth Hospital NHS Foundation Trust), Rüdiger Lange(Deutsches Herzzentrum München), Axel Haverich(Medizinische Hochschule Hannover), Gideon Cohen(Sunnybrook Health Science Centre), Michael Rosenbloom(University of Washington), Gilbert Schorlemmer(St. Mark's Hospital), Joseph Zacharias(Blackpool Teaching Hospitals NHS Foundation Trust), James G. Abel(University of British Columbia), Jeffrey Swanson(Dana-Farber Cancer Institute), Michael J. Moulton(Nebraska Medical Center)
Cited by 13
Related Papers
2014 ESC Guidelines on the diagnosis and treatment of aortic diseases
|European Heart Journal|2014|4.4k
Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab
|Science Translational Medicine|2011|670
Intramural Hemorrhage of the Thoracic Aorta
|Circulation|1995|506
Functional assessment and transplantation of the donor heart after circulatory death
|The Journal of Heart and Lung Transplantation|2016|255
Surgical Explantation After TAVR Failure
|JACC: Cardiovascular Interventions|2021|157